Hypotiroidism, hemolytic anemia and cryoglobulinemia in a patient with hepatitis C virus infection: Efficacy of treatment with alpha-interferon [8];Hipotiroidismo, anemia hemolítica y crioglobulinemia en una paciente con hepatitis por virus C: Eficacia del tratamiento con interferón alfa

Anales de Medicina Interna

Volumn 20, Issue 7, 2003, Pages 391-392

  Castellano Higuera, A ^a   Gonzalez Reimers E ^a   Alarco Hernandez B ^a   Santolaria Fernandez F ^a   Rodriguez Gaspar M ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; CRYOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN;

AGED; CASE REPORT; CHRONIC HEPATITIS; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LETTER; THYROID DISEASE; TREATMENT OUTCOME; VIRUS HEPATITIS;

AGED; ANEMIA, HEMOLYTIC; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPOTHYROIDISM; INTERFERON-ALPHA; TREATMENT OUTCOME;

EID: 0042155841     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus in type II cryoglobulinemia. N.Engl J Med 1992; 327: 1490-5.
2. Gumber SC, Chopra S. Hepatitis C: a multifaceted desease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
3. Jones MP, Pandak WM, Moxley GF. Chronic diarrhea in essential mixed cryoglobulinemia: a manifesation of visceral vasculitis? Am J Gastroenterol, 1991; 86: 522-4.
4. Lamprecht P, Moosig F, Gause A, Herlyn K, Csemok E, Hansen H, et al. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2001; 60: 385-90.
5. Chao TC, Chen CY, Yang YH, Chen PM, Chang FY, Lee SD. Chronic hepatitis C virus infection associated with primary warm-type autoimmune haemolytic anaemia. J Clin Gastroenterol 2001; 33: 232-3.
6. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, et al. Long term outcome of interferon-a induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 2001; 86: 1925-30.
7. Koff RS. Interferon a for chronic hepatitis C: Reducing the uncertainities. Ann Intern Med 1997; 127: 918-20.
8. García Gracia B, Sancho Bueso T, Gil Catalinas F, Bemardino de la Sema JI, García Puig J. Isquemia de miembros inferiores en pacientes con hepatitis por virus de la hepatitis C tratados con interferón alfa. Rev Clin Esp, 2001; 201: 283-4.
9. Deutsch M, Dourakis S, Manesis EK, Gioustozis A, Hess G, Horsch A, Hadziyannis S. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997; 26: 206-10.
10. Watanabe U, Hasimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-a therapy for chronic hepatitis C. Am J. Gastroenterol 1994; 89: 399-403.